http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014200202-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e6ab9a985cec5c0927fa76eb016842e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb29f3c0a03ebc58cd782f620491bd91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d3f1bfec8ac94cca9554e3c17db5c6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4022bd94f9a2fc6a9eb32aeabcaa0b11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba3af9411e2645a751e2d98c8503bd67
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
filingDate 2012-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b97c184ae5b770376ef4a2e7cd191462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df34a925df3be186fa42e289a5fd2ecb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da335db53dbe8e32938d40b42981fb9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa0c24c3fbe8d39791252e4f26a3ef90
publicationDate 2014-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2014200202-A1
titleOfInvention Use of estetrol as emergency contraceptive
abstract The present invention relates to a new use of tetrahydroxylated estrogens such as estetrol (1,3,5(10)-estratrien-3,15α,16α,17β-tetrol), namely in a method of emergency contraception. The method of emergency contraception according to the invention comprises the oral administration of estetrol in a single dose within 120 hours of sexual intercourse.
priorityDate 2011-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7732430-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004192620-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7871995-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005032755-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10063622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457945584
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127508829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID244459013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID325757076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407416700

Total number of triples: 32.